02/04/2022

Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2

Coronavirus disease 2019 (COVID-19) is an illness caused by the new coronavirus severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). It has affected public health and the economy globally. Currently approved vaccines and other drug candidates could be associated with several drawbacks which urges developing alternative therapeutic approaches.

Matéria original

Anterior

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
Próxima

Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism